Veterinary Medicines

CORTEXILINE

Not authorised
  • NEOMYCIN SULFATE
  • Methylprednisolone
  • Benzylpenicillin procaine monohydrate
Download as PDF

Product identification

Medicine name:
CORTEXILINE
Active substance:
  • NEOMYCIN SULFATE
  • Methylprednisolone
  • Benzylpenicillin procaine monohydrate
Target species:
  • Cattle
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • NEOMYCIN SULFATE
    169.01
    milligram(s)
    /
    1.00
    millilitre(s)
  • Methylprednisolone
    4.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Benzylpenicillin procaine monohydrate
    200.57
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        60
        day
      • Milk
        9
        day
  • Subcutaneous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01RV01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/9861360 7/1985
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 24/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."